Pharma Foods InternationalPharma Foods International Co., Ltd.2929東証プライム食料品FY ending Jul 2025, consolidated, J-GAAP

Pharma Foods International FY ending Jul 2019 results

About 81% of Pharma Foods International's sales come from Bio Direct Value, with Bio Functional Seeds and Bio Medical making up much of the rest.

Out of every ¥100 of sales, about ¥5 is left as operating profit.

Where the money goes

For every ¥100 Pharma Foods International sells, how much goes where, and how much is kept.

FY ending Jul 2019

Margin funnel (derived from reported values)Gross margin 81.0% → Operating margin 5.5% → Net margin 4.7%

Revenue by business segment, and the profit each one keeps.

FY ending Jul 2019

※ Segment figures include inter-segment sales and do not sum to the company total

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第26期(2022/08/01－2023/07/31)
ID S100S2IX2023-10-25Open
EDINET (FSA Japan)
有価証券報告書－第24期(令和2年8月1日－令和3年7月31日)
ID S100MMP32021-10-20Open
EDINET (FSA Japan)
有価証券報告書－第23期(令和1年8月1日－令和2年7月31日)
ID S100JY6D2020-10-20Open

Extracted from XBRL: 43 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.